Skip to main content
NDRA logo

NDRA · ENDRA Life Sciences Inc.

$4.60 +0.03 (+0.55%) At close · Aug 7
Market Cap
$5.84M
Shares
1.27M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2024
Executive Total
Francois Michelon $314,650
Michael Thornton $222,082
Alexander Tokman $215,185
Irina Pestrikova $126,298
Richard Jacroux $95,900
Fiscal 2023
Executive Total
Francois Michelon $646,787
Michael Thornton $531,977
Irina Pestrikova $214,724

Executive changes

Person Change Filed
Michael Harsh Appointed 2025-12-15
Alexander Tokman Appointed 2025-12-15
Anthony DiGiandomenico Appointed 2025-12-15
Louis J. Basenese Appointed 2025-12-15
Michael Thornton Resigned 2025-11-28
Alexander Tokman Appointed 2024-08-13
Alexander Tokman Appointed 2024-08-13
Francois Michelon Resigned 2024-08-13
Francois Michelon Resigned 2024-08-13
Richard Jacroux Appointed 2024-08-09
Irina Pestrikova Resigned 2024-08-09
Key facts CIK 1681682 CUSIP 29273B500 13F (30d) 1 filings 1 filers Visit website